Modernatx, Inc.

Kapil Bahl

Giuseppe Ciaramella

Sunny Himansu

Eric Yi-Chun Huang

Andrew J Bett

Tal Zaks

Amy Espeseth

Sayda Mahgoub Elbashir

Lan Zhang

Christine Shaw

Pedro Cejas

Dai Wang

Tai Zaks

The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

RSV RNA vaccines

The disclosure describes respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Respiratory syncytial virus vaccine

Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.

CHIKV RNA vaccines

Infectious disease vaccines

Aspects of the disclosure describe compositions that comprise RNA polynucleotides having an open reading frame encoding one or more Zika virus antigens. Methods for preparing and using the compositions are also described.

Zika RNA vaccines

Growing community of inventors

Medford, MA, United States of America

Kapil Bahl